Infliximab-dyyb

Next

Inflectra® ,

Infliximab-dyyb

Disease
Crohn's disease , Ulcerative colitis ,
Drug Class
Biologics/Biosimilars
Delivery Method
iv
IV or
Brand name:
Inflectra®

(This drug is a biosimilar to Remicade©)

,
Drug name:
Infliximab-dyyb
Drug type
Anti-TNF
Recommendations for pregnancy

Low risk

Recommendations for breastfeeding

Limited human data: probably compatible

Most common side effects

Common side effects include respiratory infections (sinus infections or sore throat), headache, coughing, and stomach pain.

Other

Serious infections have included tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that have spread throughout the body or cause infections in certain areas. Lymphoma, including hepatosplenic T-cell lymphoma, and other cancers, have also been reported.

Learn more about Biologics/Biosimilars

Infliximab-dyyb

Video Length

Infliximab-dyyb